Skip to content
Providing the evidence base to reduce harmful AOD use in
Aboriginal and Torres Strait Islander communities
The Community pharmacotherapy program provides support, information and advice for clients, pharmacists, and medical practitioners involved in methadone and buprenorphine treatment across Western Australian. The program assists people who are dependent on opioids to locate services, access treatment, and transfer between states and overseas.
The Community pharmacotherapy program also provides training and resources to medical practitioners and pharmacists who are, or wish to become, authorised to provide methadone and buprenorphine treatment.
Abstract adapted from Drug and Alcohol Office of Western Australia
Community pharmacotherapy program
Ph: (08) 9219 1907
Fax: (08) 9471 0444
Drug and Alcohol Office of Western Australia
7 Field Street
Mt Lawley WA 6050
PO Box 126
Mt Lawley WA 6929
Ph: (08) 9370 0333